Connect with us

Science

Best Stocks To Invest In Right Now? 3 Biotech Stocks To Know

Check out these biotech players under the microscope now.
The post Best Stocks To Invest In Right Now? 3 Biotech Stocks To Know appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Published

on

3 Biotech Stocks For Your June Watchlist

When looking for the most active stocks today, investors would likely think of meme stocks. However, biotech stocks may also come to mind as well in the stock market today. As most seasoned investors would know, the biotech industry is jam-packed with exciting news for traders to digest. Namely, the biotech industry is filled with companies that conduct research on life-improving treatments. Given the vast array of illnesses to be cured today, investors would have plenty of companies to choose from now.

For instance, a very prominent example would be COVID-19. Following the outbreak of the pandemic, countless biotech companies sprang into action to develop a vaccine. Now, companies such as Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) are in the spotlight thanks to their vaccines. In the case of Moderna, the company’s vaccine continues to make its way across the globe now. Just yesterday, news broke of the U.S. government reportedly being in negotiations with Moderna to secure additional vaccine doses for other countries. Elsewhere, investors appear keen on Novavax’s upcoming vaccine candidate as well. Analysts from both B. Riley Securities and Jefferies hit the company’s shares with a Buy rating, citing that the company is nearing regulatory approval. As it stands, both MRNA stock and NVAX stock have more than tripled in value over the past year.

At the same time, even the bigger names in the biotech field are not sitting idly by. Take Biogen (NASDAQ: BIIB) for example who just received FDA approval for its Alzheimer’s treatment this week, an industry first. As a result, BIIB stock is currently looking at gains of over 40% this week. With all that in mind, here are three trending biotech stocks in the stock market now.

Best Biotech Stocks To Buy [Or Sell] Now

BioNTech

Starting us off today is BioNTech, the other half to the pioneering Pfizer (NYSE: PFE) vaccine. For the uninitiated, BioNTech is a German biotech company that develops and manufactures active immunotherapies. Aside from the coronavirus vaccine, the company’s developmental pipeline also focuses heavily on a wide array of cancers. Through this comprehensive oncology pipeline, BioNTech is currently working with healthcare players such as Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi (NASDAQ: SNY). Now, BNTX stock is currently looking at gains of over 400% in the past year. Could it still have room to run this year?

Well, for one thing, the company’s work in the coronavirus vaccine field is far from over. Late last month, BioNTech’s vaccine candidate received its first authorization in the European Union for use in adolescents. Given the age group’s arguably underdeveloped immune systems, this is a remarkable development for BioNTech. According to the company, the vaccine can now be applied to individuals between the ages of 12 to 15 years old. Not only would this serve to accelerate vaccination efforts globally, but it would also provide BioNTech with additional market reach.

If that wasn’t enough, the company could also be getting additional orders from the U.S. According to the Washington Post, the Biden administration is looking to buy 500 million doses of BioNTech’s vaccine to redistribute to other countries. For now, it is estimated that all doses will likely be distributed by the first half of 2022. Covax, the World Health Organization (WHO)-backed initiative, will be in charge of the global distribution. By and large, this marks a win-win situation as BioNTech can market more vaccines while countries in need receive critical aid. Does this make BNTX stock a top buy for you now?

Source: TD Ameritrade TOS


Read More

Inovio Pharmaceuticals Inc.

Another biotech company to know now would be Inovio Pharmaceuticals Inc. In brief, the company primarily focuses on the discovery, development, and commercialization of synthetic DNA products. Said products serve to treat infectious diseases, cancer, and sexually transmitted diseases. Moreover, Inovio also boasts a massive list of notable partners and collaborators from both governments and private organizations. These include but are not limited to AstraZeneca (NASDAQ: AZN), the Bill & Melinda Gates Foundation, the U.S. Department of Defense, and the National Institutes of Health.

Impressive operations aside, INO stock appears to be catching investors’ attention now. This appears to be the case as the company’s shares are up by over 45% in the past month. For the most part, this would be thanks to the company’s work on its supposed DNA vaccine, INO-4802. As of last month, Inovio’s vaccine candidate produced strong signs of efficacy across multiple strains of the virus in preclinical studies. Notably, this could potentially make it a “next-generation Pan-COVID-19 vaccine candidate”, according to Inovio.

Aside from that, the company is also hard at work on its earlier COVID-19 vaccine candidate INO-4800 as well. Earlier today, Inovio announced that it would be expanding its current partnership with Chinese biotech company, Advaccine. The duo will now be conducting global Phase 3 trials for INO-4800 in a two-dose regimen. In terms of subjects, individuals 18 years and older across the Latin America and Asia regions will be involved. CEO Dr. Joseph Kim cites global vaccination rates being below 10% as a key driver to accelerate these tests. Could INO stock be worth adding to your portfolio because of all this?

best biotech stocks to buy (INO stock)
Source: TD Ameritrade TOS

[Read More] 4 Artificial Intelligence Stocks To Watch Right Now

Connect Biopharma Holdings Ltd

Following that, we have Connect Biopharma. For some context, it is a global clinical-stage biopharmaceutical company looking to treat patients with chronic inflammatory diseases. It does so via the development of therapies derived from T cell-based research. For a sense of scale, the company has operations in China, the U.S., and Australia. On top of that, Connect Biopharma also runs additional clinical development activities in Europe. In a nutshell, the company uses small molecules and antibodies to target T cells, which in turn serve to screen and discover potent drug candidates.

If anything, Connect Biopharma’s portfolio continues to expand significantly and investors seem to be reacting accordingly. Diving right into it, the company announced the commencement of a Phase 2 trial for its Asthma treatment, CBP-201. Since the announcement early on May 12, CNTB stock has surged by over 20%. Specifically, the treatment is being evaluated for use in adults with moderate-to-severe persistent asthma. Approximately 300 patients across 80 clinical sites in the U.S., China, the European Union, the U.K., Ukraine, and South Korea.

According to Dr. Edward Kerwin, founder of the Clinical Research Institute, Allergy and Asthma Center, this is a significant development. He said, “Beginning enrollment on the CBP-201 clinical trial offers hope in the pursuit of new, effective treatments for severe asthma.” Given the scale and importance of Connect Biopharma’s latest project, we could be looking at exciting times ahead for CNTB stock. Would you agree?

best biotech stocks to buy right now (CNTB stock)
Source: TD Ameritrade TOS

The post Best Stocks To Invest In Right Now? 3 Biotech Stocks To Know appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Government

White House Ready To Lift Ban On Foreign Travel But Only For The Vaccinated

White House Ready To Lift Ban On Foreign Travel But Only For The Vaccinated

As Canada prepares to welcome fully-vaxxed Americans into the country for the first time since the pandemic started, over in Washington, plans are brewing for the…

Published

on

White House Ready To Lift Ban On Foreign Travel But Only For The Vaccinated

As Canada prepares to welcome fully-vaxxed Americans into the country for the first time since the pandemic started, over in Washington, plans are brewing for the US to reopen travel only to foreigners who can prove they are fully vaccinated.

According to a Reuters exclusive, President Biden and his administration are preparing a plan to require nearly all foreign visitors to the US to be fully vaccinated. The new policy will replace the current border restrictions, which bar travelers from most of the world from reaching the US.

Because COVID cases are still climbing, the White House isn't ready to simply lift all travel restrictions. That's where the border restrictions come in: The Biden administration has interagency working groups working "in order to have a new system ready for when we can reopen travel." When this happens, the US will start with "a phased approach that over time will mean, with limited exceptions, that foreign nationals traveling to the United States (from all countries) need to be fully vaccinated."

Last week, Jen Psaki, the White House press secretary, said the Biden Administration planned to maintain its travel restrictions on visitors from Europe and elsewhere. The announcement was a blow to the travel industry, which had hoped that a lifting of the travel bans could increase tourism for the remaining summer months, helping hotels, airlines and other businesses that have been struggling since the start of the pandemic.

Even the liberal Washington Post complained about Biden's decision to continue restricting travel, with one opinion writer claiming that the continued moratorium on international travel was both "medically unnecessary and financially unwise," per WaPo.

However, we suspect some foreign governments might be offended when the US inevitably excludes travelers who received a foreign vaccine, including those made by Russia and China. Or when foreigners from certain countries have been shut out of the US for years, as the developing world waits for the emerging world to catch up on vaccinations.

Washington's cautiousness mirrors the return of travel restrictions in Europe, where pubic health officials are cracking down to combat the delta variant. The report comes less than a week after President Biden announced new requirements for federal workers to get vaccinated (with a handful of exceptions). But on the bright side, pretty soon, Americans might be flocking to the Caribbean to make up for two summer travel seasons spoiled by the pandemic.

Tyler Durden Wed, 08/04/2021 - 17:30

Read More

Continue Reading

Spread & Containment

China Suspends Travel, Ramps Up Testing As Delta Outbreak Hits Wuhan

China Suspends Travel, Ramps Up Testing As Delta Outbreak Hits Wuhan

China’s worst outbreak since COVID first emerged in the city of Wuhan has continued to spread, prompting authorities to intensify their efforts to crush the delta-driven…

Published

on

China Suspends Travel, Ramps Up Testing As Delta Outbreak Hits Wuhan

China's worst outbreak since COVID first emerged in the city of Wuhan has continued to spread, prompting authorities to intensify their efforts to crush the delta-driven outbreak. However, as the virus continues to elude their grasp, it's looking increasingly likely that Beijing's "zero tolerance" approach might hamstring economic growth, as analysts from Goldman Sachs warned in a recent note to clients.

More than 2 dozen cities have counted more than 300 cases over the past few weeks as the number of cases has quickly multiplied. China now has 144 medium- and high-risk areas - the most since the initial outbreak in early 2020, according to the National Health Commission.

By Monday, all of China's 31 provincial-level jurisdictions had issued notices by Monday advising people not to travel domestically. Some provincial governments singled out only medium- and high-risk regions, while others asked people to avoid all inter-provincial travel. According to the SCMP, Beijing's "zero-tolerance" approach to fighting COVID, which remains minimal compared with China's vast population, has "scared away" the tourists.

China reported 71 new COVID cases from local transmission on Wednesday, more than half of them in coastal Jiangsu province near the epicenter of Nanjiang, AP reported.

The CCP has decided to expand travel restrictions on Wednesday: ride-hailing services and public transit have been suspended in all medium- to high-risk areas. Immigration authorities have promised to "strictly restrict non-urgent, unnecessary cross-boarder travel" including restricting the issuing of passports for Chinese citizens. To try and stifle the virus before it has an opportunity to take hold, the city ordered millions of residents to undergo mandatory testing, leading to lines forming across the city. The city has also closed 17 bus lines and a handful of subway stations. Cases have been confirmed in 17 provinces and some two dozen cities, including Wuhan, which reported a handful of cases this week, per CNN.

Fears of another crushing lockdown - many Wuhan residents still have PTSD from the 70-day+ lockdown in the city that was used to crush the original outbreak, at a tremendous cost to the city's residents mental and physical health. Videos and photos shared on social media have shown empty shelves and long lines at supermarkets, as residents scramble to stock up on supplies.

"Seeing Wuhan people panic buying at supermarkets makes me feel sad. Only those who have experienced it understand how terrible it is, (we) dread a return to the days of staying at home and not knowing where the next meal is," said one Wuhan resident on Weibo.

The present outbreak began a little over a week ago in Nanjing, a city in Jiangsu province in eastern China, where nine airport cleaners were found to be infected on July 20 during a routine test. Chinese authorities have blamed the cluster on workers from Russia, who arrived at the Nanjing Lukou International Airport on July 10.

"It is believed that the cleaners did not strictly follow anti-epidemic guidelines after cleaning Flight CA910 and contracted the virus as a result. The infection further spread to other colleagues, who are also responsible for cleaning and transporting garbage on both international and domestic flights," reported state news agency Xinhua.

Given the provenance of the latest outbreak, Beijing has committed to ramp up testing of transport workers around the country. Workers at ports and borders considered high risk will be tested for the virus every other day said Li Huaqiang, a senior official with Ministry of Transport.

Earlier this week, another COVID-19 hotspot was identified in the city of Zhangjiajie, near a scenic area famous for sandstone cliffs, caves, forests and waterfalls.

Despite only confirming some 19 cases over the past week, the city ordered residential communities sealed Sunday, preventing people from leaving their homes. In a subsequent order on Tuesday, officials said no residents, and no tourists, would be allowed to leave the city. On Wednesday, the city government's Communist Party disciplinary committee issued a list of local officials who "had a negative impact" on pandemic prevention and control work who would be punished.

Far higher numbers were reported in Yangzhou, a city next to Nanjing, which has recorded 126 cases as of Tuesday. As a result, all cross-city ferry services, water tours were suspended in eastern Yangzhou on Wednesday.

But most alarmingly, the outbreak has already touched Beijing, eve though it's thousands of miles removed from the epicenter in Nanjiang. On Wednesday, 7 cases were confirmed in the capital city, prompting authorities to lock down two residential compounds.

As of this wee, China has doled out more than 1.71 billion vaccine doses to its population of 1.4 billion. Officials say 40% of the population is fully vaccinated, but the outbreak is also raising questions about the efficacy of those vaccines.

Tyler Durden Wed, 08/04/2021 - 18:00

Read More

Continue Reading

Government

Boston Mayor Indicates Opposition To Vaccine Passports, Comparing Them To Slave Papers

Boston Mayor Indicates Opposition To Vaccine Passports, Comparing Them To Slave Papers

By Zach Stieber of Epoch Times,

Boston’s acting mayor appeared on Aug. 3 to voice her opposition to requiring proof of COVID-19 vaccination, suggesting…

Published

on

Boston Mayor Indicates Opposition To Vaccine Passports, Comparing Them To Slave Papers

By Zach Stieber of Epoch Times,

Boston’s acting mayor appeared on Aug. 3 to voice her opposition to requiring proof of COVID-19 vaccination, suggesting that so-called vaccine passports would disproportionately affect minorities.

We want to make sure that we are giving every opportunity for folks to get vaccinated. When it comes to what businesses may choose to do, we know that those types of things are difficult to enforce when it comes to vaccine,” Acting Mayor Kim Janey, a Democrat, told reporters in a gaggle.

“There’s a long history in this country of people needing to show their papers. During slavery, post-slavery, as recent as—you know what immigrant population has to go through here. We heard [former President Donald] Trump with the birth certificate nonsense. Here we want to make sure that we are not doing anything that would further create a barrier for residents of Boston or disproportionally impact BIPOC communities.”

BIPOC stands for black, indigenous, and people of color.

Janey said the government wants to work closely with community organizations to make sure of broad access to the vaccines and that she backs employers who want to encourage their workers to get vaccinated.

The comments drew some pushback from rivals who are competing in the gubernatorial race.

“When we are combating a deadly virus and vaccine hesitancy, this kind of rhetoric is dangerous,” city Councilwoman Andrea Campbell said on Twitter.

“Showing proof of vaccination is not slavery or birtherism. We are too close to give ground to COVID. Science is science. It’s pretty simple—Vax up and mask up.”

“Anyone in a position of leadership should be using that position to build trust in vaccines,” said Michelle Wu, another city councilwoman.

According to Boston officials, about six in 10 residents were fully vaccinated against the CCP (Chinese Communist Party) virus, which causes COVID-19, as of July 27. Nearly half of them are white, with vaccination rates lagging among blacks and Hispanics.

New York City earlier on Aug. 3 announced that proof of vaccination, or vaccine passports, will be required to enter many establishments, including restaurants and gyms.

“The only way to patronize these businesses indoors is if you’re vaccinated,” Mayor Bill de Blasio, a Democrat, said at a press conference.

“If you want to participate in society fully, you’ve got to get vaccinated.”

The mandate may expand to other businesses, including supermarkets, a health official told The Epoch Times.

Janey became acting Boston mayor after Marty Walsh joined the Biden administration as secretary of labor. The preliminary election for the seat is slated for Sept. 14, with the general election in November.

Janey’s office later issued a statement in which the acting mayor added context to her remarks.

“While there are no current plans for business sector vaccination mandates, we are using data to inform targeted public health strategies. This includes meeting with restaurants and bars to discuss overlaps between their clientele and new COVID-19 case trends. We are working with the hospitality sector to provide vaccine access and information for customers in the form of signage, social media graphics, and on-site vaccination clinics,” she said.

“COVID-19 cases have increased in Boston with the emergence of the Delta variant, but we are still well below threshold levels that have guided policy decisions throughout the pandemic. Work with our business community will continue, as we learn to live with COVID-19.”

Tyler Durden Wed, 08/04/2021 - 18:20

Read More

Continue Reading

Trending